Numerous essential biological processes are influenced epigenetically by methylation of proteins on arginine and lysine residues. However, studies on writers, readers, and erasers of methyl-arginine marks and chemical/pharmacological modulation of protein arginine methyltransferases (PRMTs) lag far behind those of lysine methylation. The focus of this conference is to explore new mechanisms in protein arginine methylation and develop effective therapeutic strategies to harness their aberrant activities in pathogenesis. The proposed sessions will feature leaders in the transcription and epigenetics field from the mid-west region of United States. In addition, sessions will provide invaluable opportunities for the career development of graduate students and postdocs. Speakers will include engaging junior and mid-career faculty.
FASEB Conferences Diversity Statement:
FASEB is committed to sustaining diversity, equity, accessibility, and inclusion in the biological and biomedical sciences. FASEB’s goal is to create and support a conference environment that is welcoming and safe for all. FASEB believes inclusion of diverse participants, including attendees and speakers, is critical to the scientific and educational integrity of conferences. Organizers are expected to design programs that reflect this commitment. As part of FASEB’s ongoing assessment towards reaching its diversity goals, conference participants are asked to share diversity information. Any data collected from individuals is treated confidentially and used in aggregate format for internal and external review. For more information, please visit https://www.faseb.org/diversity-equity-and-inclusion